INLB — Item 9 Labs Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $33.71m
- $21.76m
Annual cashflow statement for Item 9 Labs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.689 | -9.95 | -12.3 | -10.9 | -31.2 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.07 | 7.14 | 7.08 | 6.53 | 19.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.403 | -0.261 | 3.1 | -2.88 | 7.86 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.972 | -2.39 | -1.14 | -5.99 | -2.25 |
Capital Expenditures | -0.34 | -7.51 | -0.723 | -2.24 | -5.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.023 | -0.336 | -0.164 | -1.68 | 0.442 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.363 | -7.84 | -0.887 | -3.92 | -5.16 |
Financing Cash Flow Items | — | — | — | -0.05 | -0.071 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3 | 9.14 | 1.54 | 11.3 | 6.05 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.66 | -1.1 | -0.49 | 1.37 | -1.37 |